The estimated Net Worth of Joseph M. Jr. Manko is at least $653 ezer dollars as of 13 August 2024. Mr. Manko owns over 75,000 units of Safeguard Scientifics stock worth over $540,454 and over the last 6 years he sold SFE stock worth over $0. In addition, he makes $112,199 as Independent Director at Safeguard Scientifics.
Sign up
Mr. Manko SFE stock SEC Form 4 insiders trading
Joseph has made over 9 trades of the Safeguard Scientifics stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 75,000 units of SFE stock worth $147,000 on 13 August 2024.
The largest trade he's ever made was buying 145,833 units of Safeguard Scientifics stock on 13 December 2023 worth over $349,999. On average, Joseph trades about 12,375 units every 55 days since 2018. As of 13 August 2024 he still owns at least 1,174,899 units of Safeguard Scientifics stock.
You can see the complete history of Mr. Manko stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Joseph Manko biography
Joseph M. Manko Jr. serves as Independent Director of the Company. He is the Senior Principal of The Horton Fund, an investment management firm. Previously, Mr. Manko served as the Chief Executive Officer of Switzerland-based BZ Fund Management Limited, where he was responsible for corporate finance, private equity investments, three public equity funds and the firm’s Special Situations and Event-Driven strategies (2005 -2010). Mr. Manko was a Managing Director and Head of Equity Capital Markets with Deutsche Bank in London (1997 – 2004) and a Vice President at Merrill Lynch in Hong Kong (1995 – 1997). He began his career as a Corporate Finance Attorney at Skadden, Arps, in Los Angeles (1991 – 1995). Mr. Manko currently serves on the Board of Directors of RMS Medical Products Inc., a leading developer and manufacturer of medical devices and supplies (since May 2016), and Creative Realties, Inc, a marketing technology company (since September 2018). Mr. Manko has also served on the Board of Directors of several European biotechnology companies, including NovImmune, S.A. (2006 – 2010). Mr. Manko received his Juris Doctorate from the University of Pennsylvania Law School and his Bachelor’s degree from University of Pennsylvania.
What is the salary of Joseph Manko?
As the Independent Director of Safeguard Scientifics, the total compensation of Joseph Manko at Safeguard Scientifics is $112,199. There are 6 executives at Safeguard Scientifics getting paid more, with Eric C. Salzman having the highest compensation of $543,454.
How old is Joseph Manko?
Joseph Manko is 54, he's been the Independent Director of Safeguard Scientifics since 2019. There are 4 older and 3 younger executives at Safeguard Scientifics. The oldest executive at Safeguard Scientifics, Inc. is Dr. Gary J. Kurtzman M.D., 66, who is the Sr. Advisor.
What's Joseph Manko's mailing address?
Joseph's mailing address filed with the SEC is 2235 ENTERPRISE STREET, SUITE 110, , ESCONDIDO, CA, 92029.
Insiders trading at Safeguard Scientifics
Over the last 21 years, insiders at Safeguard Scientifics have traded over $372,519 worth of Safeguard Scientifics stock and bought 877,847 units worth $3,711,567 . The most active insiders traders include Stephen Fisher, Thomas A Jr Satterfield és Michael F Cola. On average, Safeguard Scientifics executives and independent directors trade stock every 51 days with the average trade being worth of $7,022. The most recent stock trade was executed by Thomas A Jr Satterfield on 17 August 2023, trading 294,000 units of SFE stock currently worth $346,920.
What does Safeguard Scientifics do?
safeguard scientifics (nyse:sfe) provides capital and relevant expertise to fuel the growth of technology-driven businesses in healthcare, financial services and digital media. safeguard targets companies that are capitalizing on the next wave of enabling technologies with a particular focus on the internet of everything, enhanced security and artificial intelligence, which includes predictive analytics and machine learning. safeguard typically deploys between $5 million and $25 million over the course of its partnership with a company, initially investing in a series a or b round and opportunistically in a seed round. safeguard has a distinguished track record of fostering innovation and building market leaders that spans more than six decades.
What does Safeguard Scientifics's logo look like?
Complete history of Mr. Manko stock trades at Safeguard Scientifics, Wireless Telecom, One Stop Systems Inc, Creative Realities Inc és KORU Medical Systems Inc
Safeguard Scientifics executives and stock owners
Safeguard Scientifics executives and other stock owners filed with the SEC include:
-
Eric C. Salzman,
Chief Exec. Officer -
Mark A. Herndon CPA,
Sr. VP & CFO -
Mark Herndon,
Chief Financial Officer, Senior Vice President -
Robert Rosenthal,
Executive Chairman of the Board, Principal Executive Officer -
Maureen Morrison,
Independent Director -
Russell Glass,
Independent Director -
Joseph Manko,
Independent Director -
Eric Salzman,
Chief Restructuring Officer -
Seth Zuckerman,
Sr. Associate of Healthcare -
Alex A. Fuiks,
Associate -
Steven J. Grenfell CPA, CPA,
Sr. Advisor -
Dr. Gary J. Kurtzman M.D.,
Sr. Advisor -
G. Matthew Barnard,
Gen. Counsel, Sec. & Compliance Officer -
David A Kille,
Senior VP & CFO -
Brian J Sisko,
President & CEO -
Bob Rosenthal,
Director -
Jeffrey Brian Mc Groarty,
Senior VP - Finance -
Stephen T Zarrilli,
Acting Sr VP & Acting CFO -
Julie A Dobson,
Director -
John Joseph Roberts,
Director -
George Mackenzie,
Director -
Stephen Fisher,
Director -
Beth Michelson,
Director -
Ross D De Mont,
Director -
Ira M Lubert,
Director -
Thomas A Jr Satterfield,
10% owner -
Keith B Jarrett,
Director -
Peter J Boni,
President & CEO -
Jack L Messman,
Director -
George D Mcclelland,
Director -
James A Datin,
Executive Vice President -
Mara G. Aspinall,
Director -
Kevin L Kemmerer,
Sr. VP & Managing Director -
Michael J Cody,
Director -
Robert Ripp,
Director -
Anthony L Craig,
President & CEO -
Christopher J Davis,
Managing Director and CFO -
John William Sr Poduska,
Director -
Steven J Feder,
Sr. V.P. & General Counsel -
Robert E Jr Keith,
Director -
Michael F Cola,
Managing Director -
Raymond J Land,
Senior V.P. & CFO -
John A Loftus,
Sr. Vice President & CTO -
Anthony Ibarguen,
Managing Director -
Russell E Palmer,
Director